Latest news
NRx to Discuss Preservative-Free Ketamine Approval Path Aug. 10 - Stock TitanStock Titan · Fri, 07 Aug 2026 20:01:00 GMTUS FDA to hold advisory meeting to review Grail's multi-cancer test - ReutersReuters · Fri, 07 Aug 2026 18:51:34 GMTXenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 18:03:22 GMTFDA sets advisory panel for Galleri multicancer screening test - MedTech DiveMedTech Dive · Fri, 07 Aug 2026 17:39:34 GMTGRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR NewswirePR Newswire · Fri, 07 Aug 2026 15:05:00 GMTFDA Completes First-Cycle Review of Preservative-Free - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 11:00:00 GMTA vial used in products that shipped 11.9M doses remains in NRx's FDA review - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTFDA Approves Twice-Rejected Oncolytic Virus Combination for Melanoma - Oncology News CentralOncology News Central · Fri, 07 Aug 2026 10:27:13 GMT